The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeGrowth
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SMFAX | 32.97 | 0.59 | +1.82% |
| American Beacon Stephens Mid-Cap Gr A | |||
| NBNCX | 13.96 | N/A | N/A |
| Neuberger Berman International Sel C | |||
| MXVIX | 42.08 | N/A | N/A |
| Empower S&P 500® Index Investor | |||
| LYFCX | 15.03 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare C | |||
| WHIAX | 5.91 | -0.01 | -0.17% |
| Macquarie High Income Fund Class A | |||
A.I.dvisor indicates that over the last year, SGRAX has been closely correlated with GFAFX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if SGRAX jumps, then GFAFX could also see price increases.
| Ticker / NAME | Correlation To SGRAX | 1D Price Change % | ||
|---|---|---|---|---|
| SGRAX | 100% | N/A | ||
| GFAFX - SGRAX | 66% Closely correlated | +0.78% | ||
| GFACX - SGRAX | 66% Loosely correlated | +0.76% | ||
| VIGIX - SGRAX | 62% Loosely correlated | N/A | ||
| VIGRX - SGRAX | 62% Loosely correlated | N/A | ||
| VIGAX - SGRAX | 62% Loosely correlated | N/A | ||
More | ||||